Andrew Donlon

Andrew Donlon has extensive experience in the pharmaceutical industry, with a background in sales, marketing, and strategic planning. Andrew has worked in various roles at Gilead Sciences and GlaxoSmithKline, and currently serves as the Global Marketing Lead at Virtual Science. Andrew has been involved in launching innovative medications for diseases such as Hepatitis Delta Virus and HIV, and has a strong track record of successful market development and commercialization strategies. Andrew's expertise in driving global marketing initiatives and go-to-market strategies make him a valuable asset in the industry.